360biolabs is a contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics in a quality-assured environment. Diverse range of assays and biomarker endpoints for clinical trials and preclinical studies in many therapeutic areas Expertise in virology, immunology and analytical chemistry. World-class facilities with BSL-2, BSL-3 & quarantine laboratories > Quality management systems to ensure that “every sample counts”
Experienced, tailored consulting in Research, Development and Innovation. We have been engaged with the Australian research ecosystem for over 20 years and understand the research funding landscape and the industry. Our consultants have advanced qualifications in their research field, experience working in that field, as well as consulting, business, legal and/or governance experience. Our combination of technical and business skills are critical to our approach. We prioritise positive, timely and accurate communication and high quality outputs.
AnteoTech are an Australian public company headquartered in Brisbane. Our patented metal-ion-based technology is applied to improve the performance of next-generation lithium-ion batteries and in the development of diagnostic solutions in Life Sciences.
The leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy.
AusTrials is a leading private clinical research organisation, with dedicated and managed research sites in Australia. We are leaders in delivering phase II-IV interventional studies, capturing real world evidence and conducting observational research in the usual clinical setting.
The Australian Institute for Bioengineering and Nanotechnology is an integrated multidisciplinary research institute bringing together world-class researchers and cutting-edge technology with a focus on translational research.
The principal goal of Avatar is to provide specialist insurance broking services to companies that develop innovative technology. Our key advantage is objective, in-depth research on industry-specific exposures. Avatar acts for 36% of the ASX listed Pharmaceuticals, Biotechnology & Life Sciences sector. They are the market leader in placement for emerging risks70% of their client base is derived from technology, life sciences, green energy & related service providers.
BDO Australia has offices around Australia with people experienced in a broad range of services and industries. We offer leading accountancy, tax and advisory services to clients Australia-wide.
Bne Enterprise is an independent organisation which promotes BNE as a business network hub where enterprise is encouraged and knowledge is shared. We create value for our Members by expanding and promoting business to business opportunities.
Bellberry Limited is a national, private not-for-profit organisation providing streamlined scientific and ethical review of human research projects across Australia.
Beyond is an integrated product development team dedicated to early-stage product development, focusing primarily on advancing innovative products from small to medium biotechnology and pharmaceutical companies worldwide. As an Australian privately owned company, we provide flexible and nimble solutions to match the needs of our clients, whether it is a stand-alone activity or a full suite of services.
BiVACOR® is a privately held company founded in 2008.The BiVACOR is a total artificial heart designed to take over the complete function of a patient’s failing heart. The BiVACOR TAH is designed to be a long-term device that can replace the total function of the patient’s native heart.
BioCifer’s breakthrough sample preparation reagent facilitates accurate sample analysis and testing, through a simple three step protocol. No magnetic beads, no spin columns, no elution. Just mix, hold for five to ten minutes at room temperature, and your sample is ready. TNA-Cifer Reagent E is developed, tested and manufactured in Australia to meet the needs of a wide range of highly sensitive downstream molecular applications in pathology testing and diagnostics.
BioPharma Excellence by Pharmalex works closely with biopharma businesses, international regulators and health authorities, and potential investors, to confidently optimize the market potential of cutting-edge biotech innovation. Their team is a fusion of three scientific powerhouses, Pharmalex, ERA Consulting and Biopharma Excellence – under the PharmaLex brand. We combine 35+ years of empirical experience and respected regulator relationships.
Bionics Queensland connects great ideas with great minds – we bring scientists, researchers, healthcare consumers, clinicians and investors together to take bionic innovations to the next level.
Bioproton is a developer and manufacturer of enzymes, probiotics, toxin binders, surfactants and other high-quality feed additives. We have sales in over 45 countries and are committed to evolving via innovative research and development that delivers novel products for the growing global feed market.
Bond University has always dared to be different. Our founders’ vision was to create a bold educational experience that opened new doors to opportunities and transformed the career trajectories of its graduates. Bond was envisioned as a place where all students could learn from world-class industry leaders, be personally mentored by their teachers, and have access to cutting-edge technologies, equipment and resources.
Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK.
Brisbane Economic Development Agency (BEDA) drives the sustainable economic growth of the city. As Brisbane’s champion, BEDA works closely with government and private sector organisations to enhance and promote the city’s reputation globally and drive demand for Brisbane.
CAD-IT Australia supports the life science community and is driven by a clear goal: to redefine possibilities. Our expertise lies in tailor-made digital solutions, carefully crafted to tackle the specific challenges of the sector.
Our formal name is Queensland Cane Growers Organisation Ltd (QCGO) but everyone knows us as CANEGROWERS. We have been advancing and protecting the interests of cane farming families in Queensland since 1926. CANEGROWERS is a not-for-profit public company providing a professional and cohesive voice for the members of 13 local grower companies, located in all of the sugarcane regions of Queensland.
CCRM Australia is the Australian Hub of the highly successful Centre for Commercialization of Regenerative Medicine in Canada (CCRM). Established as a not-for-profit with a national focus, CCRM Australia’s mission is to address bottlenecks in the translation and commercialisation of regenerative medicine discoveries in Australia
Canary provides Product Development and Global Regulatory Affairs strategic advice and operational support to the Pharmaceutical, Biotechnology and Medical Devices sectors to expedite registration and commercialisation.
Cannatrek is a market leader in the Australian medicinal cannabis industry. As a vertically integrated, fully licenced medicinal cannabis enterprise, Cannatrek cultivates, manufactures and distributes premium plant-based therapies, from seed to patient. Cannatrek strives to improve the lives of patients with chronic conditions by providing affordable access to safe, compliant, reliable medicines.
Catalan Group is a unique science communication organisation with a twist. Instead of acting as a reporter for science news, we interpret your science stories and work together with scientists, researchers, technical professionals, and start-ups to enable them to present their own science to wider audiences.
Cook Medical develops and sells minimally invasive medical devices since 1963.Our products, manufactured in North America, Europe and Australia, are sold and delivered to 135 countries, serving almost every system in the human body and every area of the hospital. We have more than 10,000 employees globally who are all dedicated to delivering clinically effective options to physicians and better healthcare to the patients we serve.
Cool Beans is an innovative, cooling underwear designed to boost sperm health and improve the likelihood of conception for couples. As a medical device entered into the Therapeutic Goods Administration Registrar (ARTG 379655), our underwear finally involves men in the conception journey, empowering them to play an active role in building and expanding their family.
Corrs Chambers Westgarth provide legal services across the full spectrum of matters, including major transactions, projects and significant disputes, offering strategic advice on our clients’ most challenging issues.
Cytiva are a global provider of technologies and services that advances and accelerates the development, manufacture, and delivery of therapeutics. We’re bringing together a wealth of technical expertise and talent, broad and deep portfolio, and exceptional service to help researchers and biopharma advance therapeutics at every stage: from discovery to delivery.
Danbar Consulting works with Universities, Research Institutes, Government and the Private Sector to plan and deliver projects that create significant social, economic and opportunity value with a focus on Life Sciences, Health and Education sectors.
De Motu Cordis is a clinical based start up based in Brisbane that is developing a product platform for the emergency treatment of life-threatening conditions. DMC have developed a needle-free drug device combination for the immediate treatment of anaphalaxis.
Deloitte has a dedicated life sciences and health team. They strive to support clients in addressing the challenges of today’s life sciences and health care industry. We engage design, digital and data to help clients develop innovative business and digital solutions.
EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
Emerson has the automation expertise and technology to solve your greatest cGMP manufacturing challenges and create effective solutions for improving your data management, real-time product quality, reliability, and operating costs
FB Rice is a top tier leading Australian Intellectual Property firm with offices across the country and an established presence across New Zealand and South-East Asia. They extend advice beyond a pure IP focus to a more strategic, commercial level.
Fitgenes is a trusted supplier of DNA-based health and wellness products to more than 1000 certified, independent health practitioners globally. ‘Fitgenes’ products unlock your DNA and provide the ultimate in personalised health, helping practitioners determine your precise dietary needs based on how you were made.
The Gold Coast Health and Knowledge Precinct is a global business destination recognised for transforming lives through healthcare innovation, new knowledge and next-generation technologies.
Graphics et al. offers subscription software for creating scientifically accurate images and animations without the need for a graphic designer. Their user-friendly interface and extensive library of over 10,000 digital assets enable users to create visually stunning diagrams and automations quickly. Their mission is to simplify scientific communication for all users. They cater to various industries, including healthcare, clinical trials, scientific manufacturing, medtech, laboratory training, and research.
Griffith Hack are leading attorneys, specialising in intellectual property, trademarks & patents. Griffith Hack advises small enterprises, big corporations, individual investors, universities and research institutions.
Griffith University is ranked amongst the top 3% of universities globally, and has over 50,000 students spread across 5 campuses. Griffith’s health and bioscience research institutes collaborate with industry and public health sectors to deliver global benefits through outcomes such as novel drug leads, vaccines for combating infectious diseases, and healthy living programs.
Compounds Australia, located within the Griffith Institute for Drug Discovery, provides cost-effective sample management and logistics throughout the drug discovery pipeline. By securely storing and curating sample libraries, we allow translational health researchers worldwide to outsource their sample and natural product logistics and focus on results.
The Menzies Health Institute Queensland (MHIQ) conducts research to understand health factors and develop strategies for improving wellbeing. Their three programs focus on Disability and Rehabilitation, Healthcare Practice and Survivorship, and Infectious Diseases and Immunology, aligning with health priorities. With additional resources like a Clinical Trial Unit, Gold Coast BioBank, and expertise in biostatistics and health economics, MHIQ emphasizes innovation, research translation, and collaborations with clinical and community partners. Their aim is to enhance health and quality of life for individuals, families, and communities.
Griffith University's Clinical Trial Unit, located within the Gold Coast Health and Knowledge Precinct and adjacent to the Gold Coast University Hospital, provides state-of-the-art facilities and professional coordination services to phase I-IV clinical trials. Supporting university staff and collaborators to conduct a wide range of trials, but also offering professional clinical trial site services to commercial clients such as global pharma, contract research organisations and the biotech and nutraceutical industry.
Hear and Say is Queensland’s specialised provider of audiology and speech pathology for all people with hearing loss. We operate state-wide and support people of all ages – from newborn babies, to toddlers, school age children and adults.
Immunexpress is developing technology to accurately rule-in or rule-out sepsis in patients suspected of infection. Lack of reliable diagnostics leads to the over-treatment of sepsis, creating an overwhelming burden to healthcare systems, hospitals, clinicians, nurses, payers and antibiotic stewardship efforts. Our goal is to transform sepsis diagnostics by providing clinicians with the technology to rapidly enable and confidently make the right treatment decisions.
Impact Innovation are an award-winning team specialising in innovation and commercialisation throughout the Asia-Pacific region.
Implicit Bioscience is a Brisbane- and Seattle-based biotech company developing a first-in-class biologic drug in the new field of immunoneurology. lead therapeutic candidate IC14 is an investigational anti-CD14 monoclonal antibodyIC14 regulates pathogenic inflammatory responses to infection and injury, and has great potential across a variety of disease areas. Right now, we are focused on testing its efficacy in the fight against Motor Neurone Disease (MND) or Amyotrophic lateral sclerosis (ALS), and Coronavirus (COVID-19).
The University of Queensland's Institute for Molecular Bioscience (IMB) is a renowned global leader in multidisciplinary life sciences research. With a team of 500 researchers from around the world, IMB focuses on disease discovery, application, and sustainable futures. Their research has resulted in the creation of 12 successful spin-out companies, generating international impact and attracting substantial investments to Queensland. IMB is a preferred partner for national and international pharmaceutical, biotech, and agricultural companies, leading to significant collaborations, including Australia's largest biotech deal and contributing to 50% of UQ's patent income.The University of Queensland's Institute for Molecular Bioscience (IMB) is a renowned global leader in multidisciplinary life sciences research. With a team of 500 researchers from around the world, IMB focuses on disease discovery, application, and sustainable futures. Their research has resulted in the creation of 12 successful spin-out companies, generating international impact and attracting substantial investments to Queensland. IMB is a preferred partner for national and international pharmaceutical, biotech, and agricultural companies, leading to significant collaborations, including Australia's largest biotech deal and contributing to 50% of UQ's patent income.
Intellect Labs helps ambitious businesses with R&D Tax Incentive, Patent Box, Grant Strategy and IP centric projects across the medtech, biotech, food and beverage, recycling and manufacturing industries. We collaborate with an expandable network of IP experts to assist our clients to leverage the ideas and products they develop.
Intergyre is a uniquely independent energy company. We support the journey to a stable, dependable, net zero energy system through delivering the flexible electricity solutions that underpin it. Our power stations provide secure, flexible energy to consumers, and help the grid to take on more and more renewables.
The Australian Institute of Tropical Health and Medicine (AITHM) is a flagship research institute of James Cook University based in the tropics of northern Australia. Australia’s only dedicated tropical health and medicine research institute, AITHM is focussed on solving problems of importance to the tropics, leading to improvements in health systems and healthcare delivery, improved biosecurity, and enhanced health outcomes for Australians and our neighbouring tropical nations.
James Cook University (JCU) is one of the world’s leading institutions focusing on the tropics. With main campuses in the tropical cities of Townsville, Cairns and Singapore, JCU’s teaching and research are shaped by the university’s presence in Asia and its proximity to the wet tropics, dry savannahs and iconic great Barrier Reef. JCU’s focus is on the health, environment and populations of tropical regions. JCU has the Australian Institute of Tropical Health & Medicine and the Queensland Tropical Health Alliance.
James & Wells experience ranges from managing large IP portfolios for international corporations, right through to protecting the ideas of start-ups, and everything in between.
KE Select is an Australian based, leading Scientific & Medical Recruitment Partner for organisations within the Life Science, Medical, Clinical, Hospital and Healthcare space. Director Kerry McMahon, BSc Biomedical Science has over 15 years’ experience carrying out Executive Search, Permanent and Contract based recruitment projects in ANZ and more recently into APAC. Kerry and her team are passionate about tailoring every client’s needs. The focus for KE Select is to build and maintain personal longterm relationships.
Kira Biotech is an Australian biotech company focused on developing immunomodulatory compounds to treat immune system disorders. Their lead candidate, KB312, is a selective monoclonal antibody that depletes activated immune cells, aiming to restore immune balance and tolerance. With venture capital funding, Kira Biotech is advancing KB312 through preclinical development and phase 1 clinical trials. The company is led by renowned rheumatologist and immunologist, Dr. Dan Baker, along with a team of drug development experts.
Knight Frank work in partnership with our commercial and residential clients to deliver exceptional results and unlock opportunities, together. They are the world’s largest privately-owned property consultancy, we have the distinct advantage of taking a longer term approach and investing in our client relationships versus being driven by the bottom line.
Laronix has developed Bionic Voice, the world’s first smart wearable electronic voice prosthesis for laryngectomy people (larynx amputees or laryngectomees). Bionic Voice substitutes and regeneratesnthe missing "voice source” for laryngectomees.It is naturally controlled by respiration and has an exceptionally high voice quality. The Voice is generated by a smart algorithm and can be trained in its future generation to reach a voice quality resembling the patient’s own.
Logan Office of Economic Development (LOED) is a division of Logan City Council, with the objective of growing the city’s economy through working with investors, businesses and other stakeholders to promote positive economic outcomes.
MTPConnect is a not-for-profit organization in Australia that aims to accelerate the growth of the medical technology, biotechnology, and pharmaceutical (MTP) sector. It was established in December 2015 by the Australian Government as an independent organization. MTPConnect focuses on strengthening connections between research and industry to maximize opportunities for scientific and technological breakthroughs, as well as their translation and commercialization. Their key areas of focus include increasing collaboration and commercialization, improving management and workforce skills, enhancing access to global supply chains and international markets, and optimizing the regulatory environment.MTPConnect raises awareness, facilitates collaboration, aggregates knowledge, and jointly funds projects that address sector growth priorities and identified constraints and gaps. They have established key hubs in Adelaide, Perth, and Brisbane, along with their head office in Brighton, Victoria. The MTPConnect Board, led by Hon Jaala Pulford, consists of respected industry leaders.MTPConnect also runs various programs funded by the Medical Research Future Fund (MRFF) and other initiatives, supporting research and development in the MTP sector.
Magnetica is an MRI System Original Equipment Manufacturer (OEM) in the clinical and research MRI markets globally. Bringing together the pedigree of these MRI and NMR sub-system OEMs is a transformational event for Magnetica, and the clinical and research MRI markets Magnetica serves and enables.
McCullough Robertson is a leading Australian law firm, operating across multiple offices. With a history spanning over 95 years, they have gained the trust of major corporations, financial institutions, governments, and high net worth individuals. Their expertise extends to various industries, including mining, energy, food, real estate, technology, healthcare, and government. McCullough Robertson prioritizes building long-term relationships with their extensive client base, offering reliable advice for their most critical challenges.
The MRCF Collaboration, established and managed by Brandon Capital Partners, provides seed and venture capital investment to support the development and growth of Australian and New Zealand life science companies. The MRCF is a unique collaboration between major Australian superannuation funds, over 50 leading medical research institutes and research hospitals in Australia and New Zealand and CSL. The MRCF supports the development and commercialisation of biomedical discoveries originating from these member research organisations, providing both capital and expertise to guide the successful development of new therapies. Current MRCF funds are the MRCF3 ($200 million) and the MRCF-BTF ($230 million). The MRCF is supported by the Australian and New Zealand governments, as well as the state governments of Victoria, New South Wales, Western Australia, Queensland, South Australia and the Australian Capital Territory
The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.
Melcare is a Life Science company with core competencies in thetherapeutic use of honey. Our products are designed to support and improve treatment outcomes in the areas of eye care, wound and skin care, nasal care and the symptoms of the common cold.
Merck offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services, and digital offerings help create solutions for people globally and a sustainable future for generations to come.
Microba is a microbial genomics company providing the public with access to cutting-edge technology to analyse their personal gut microbiome. Using one of the most advanced sequencing technologies, Microba empowers consumers to gain a deeper understanding of their personal microbiome.Microba's therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome.